In Vitro Diagnostics Analyzers Market Analysis Reveals Impressive Growth Forecast Through 2028 with Focus on Key Drivers and Trends - ResearchAndMarkets.com
29 Dec 2023
DUBLIN--(BUSINESS WIRE)--The "In Vitro Diagnostics (IVD) Analyzers: Global Market" report has been added to ResearchAndMarkets.com's offering.
'In Vitro Diagnostics (IVD) Analyzers: Global Market'
The global market for IVD analyzers was valued at $12.2 billion in 2022, and is projected to reach $16.3 billion by the end of 2028 at a CAGR of 4.7 % during the forecast period of 2023 to 2028. The increasing elderly population, growing incidence of chronic diseases, widening use of diagnostics for prevention and monitoring, and growing adoption of PoC testing are driving market growth.
Based on analyzer type, the market is categorized into immunoassay analyzers, clinical chemistry analyzers, hematology and hemostasis analyzers, molecular diagnostic analyzers and PoC analyzers. The molecular analyzers segment, which held the third largest market share in 2022, is expected to show the highest CAGR, at 6.0%, during the forecast period. This segment's share is attributed to the growing incidence of cancer and cancer-related diseases.
The market is also segmented into semi-automated and fully automated analyzers. The semi-automated segment accounted for 67.2% of the market in 2022. The fully automated segment is expected to grow at a higher CAGR of 6.4% during the forecast period, due to an increasing focus on automated and modulator laboratories. Its market share is expected to increase to 35.5% in 2028, up from 32.8% in 2022.
Based ontherapeutic area, the market for IVD analyzers is segmented into infectious diseases, diabetes, cardiology, oncology, nephrology and others. Infectious diseases accounted for 46.25 of the market in 2022 and this segment is expected to grow at a CAGR of 4.3% during the forecast period. The diabetes segment is a distant second, with 9.7% of the market in 2022, and it is expected to grow at a CAGR of 5.8% during the forecast period.
In this report, the end users of IVD analyzers consist of diagnostic laboratories, hospitals and clinics, research institutions, and others. Diagnostic labs accounted for 52.3% of the market share in 2022, and the segment is expected to grow at a CAGR of 5.0% during the forecast period. The increasing number of large laboratory networks with advanced instruments is driving the growth of this segment.
The current report highlights the current and future market potential of in vitro diagnostics analyzers along with an analysis of the drivers, restraints, challenges, and emerging trends in the market.
The Report Includes
39 data tables and 34 additional tables
An analysis of the global market for in vitro diagnostics (IVD) analyzers
Analyses of global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
Estimate of the actual market size and revenue forecast, and corresponding market share analysis by test type, level of automation, application, end user and region
Facts and figures pertaining to the market growth drivers, opportunities and restraints, innovations and prospects, technologies, regulatory scenarios, and COVID-19's impact on the IVD industry
Discussion of sustainability trends and factors in the IVD analyzer market, with emphasis on consumer attitudes, companies' ESG scores, future of ESG, case studies and the ESG practices of leading companies
Overview of the emerging new technologies and patents in the market
Analysis of the major vendors in the market as well as the competitive landscape, including company market shares, financials, M&A deals and venture fundings
Profiles of the leading market players, including Siemens Healthineers, Abbott Laboratories, F. Hoffmann-La Roche, Bio-Rad Laboratories, Danaher Corp., and Thermo Fisher Scientific
Key Attributes:
Report Attribute
Details
No. of Pages
138
Forecast Period
2023 - 2028
Estimated Market Value (USD) in 2023
$12.9 Billion
Forecasted Market Value (USD) by 2028
$16.3 Billion
Compound Annual Growth Rate
4.7%
Regions Covered
Global
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Summary and Highlights
Chapter 3 Market Overview
Chapter 4 Market Dynamics
Chapter 5 Market Breakdown by Analyzer Type
Global Market for IVD Analyzers
Market Analysis
Immunoassay Analyzers
Market Size and Forecast
Clinical Chemistry Analyzers
Hematology and Hemostasis Analyzers
Molecular Diagnostic Analyzers
Point-of-Care Analyzers
Other Analyzers
Chapter 6 Market Breakdown by Level of Automation
Semi-Automated Analyzers
Fully Automated Analyzers
Chapter 7 Market Breakdown by Therapeutic Area
Oncology
Cardiology
Nephrology
Chapter 8 Market Breakdown by End User
Diagnostic Labs
Hospitals and Clinics
Research Institutions
Other Users
Chapter 9 Market Breakdown by Region
Chapter 10 ESG Development
Sustainability in the IVD Analyzer Industry: An ESG Perspective
Key ESG Issues
Environmental Performance of IVD Companies
Social Performance of Key IVD Analyzers Companies
Governance Performance of IVD Analyzer Companies
Consumer Attitudes toward ESG in the IVD Analyzer Market
Case Study
Concluding Remarks
Chapter 11 Emerging Technologies and Developments
Technologies in the Market
Integration of AI and Machine Learning
Digital Morphology
Connected PoC Devices
Microfluidics and Miniaturization
Chapter 12 Regulatory Scenario
Chapter 13 M&A Analysis
Chapter 14 Competitive Landscape
Chapter 15 Company Profiles
Becton, Dickinson And Co.
Danaher
Quidelortho
Siemens Healthineers
For more information about this report visit https://www.researchandmarkets.com/r/5ruu6p
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.